- A case of histoplasmosis in a patient with MDS/MPN-U
-
Rastogi P, Sharma P, Kumar N, Rudramurthy SM, Varma N, Varma S
- KMID: 2353504
- Blood Res.
- 2016 Sep;51(3):206-207.
- doi: 10.5045/br.2016.51.3.206
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hemophagocytic lymphohistiocytosis secondary to histoplasmosis
-
Karthik Bommanan BK, Naseem S, Varma N
- KMID: 2413323
- Blood Res.
- 2017 Jun;52(2):83-83.
- doi: 10.5045/br.2017.52.2.83
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Multifocal large aggregates of pseudo-Gaucher cells in chronic myeloid leukemia
-
Sharma P, Kumar N, Varma N
- KMID: 2429315
- Blood Res.
- 2018 Sep;53(3):187-187.
- doi: 10.5045/br.2018.53.3.187
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia
-
Rajpal S, Nampoothiri RV, Sreedharanunni S, Parihar M, Malhotra P, Varma N
- KMID: 2451043
- Blood Res.
- 2018 Jun;53(2):180-181.
- doi: 10.5045/br.2018.53.2.180
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience
-
Prakash G, Jain A, Sahu K, Bal A, Singh C, Basher R, Singh H, Mishra K, Jandial A, Lad D, Khadwal A, Srinivasan R, Das A, Varma N, Varma S, Malhotra P
- KMID: 2520582
- Blood Res.
- 2021 Sep;56(3):134-140.
- doi: 10.5045/br.2021.2021039
Background: This study evaluated the outcomes of patients with refractory/relapsed Hodgkin lymphoma (RRHL) treated with a bendamustine-based regimen in combination with ifosfamide, etoposide, and vinorelbine (VIBE). Methods: Consecutive RRHL patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature
-
Bommannan , Sachdeva M, Malhotra P, Kumar N, Sharma P, Naseem S, Ahluwalia , Das R, Varma N, Prakash G, Khadwal A, Srinivasan R, Varma S
- KMID: 2172741
- Blood Res.
- 2016 Mar;51(1):23-30.
- doi: 10.5045/br.2016.51.1.23
BACKGROUND: Plasma cell leukemia (PCL) is a rare and aggressive plasma cell neoplasm. In PCL, clonal plasma cells comprise ≥20% of the peripheral blood (PB) leukocytes and/or the absolute clonal... -
- CITED
-
- Close
- SHARE
-
- Close
- Inherited thrombophilia profile in patients with recurrent miscarriages: Experience from a tertiary care center in north India
-
Kumar N, Ahluwalia , Das R, Rohilla M, Bose S, Kishan H, Varma N
- KMID: 2314069
- Obstet Gynecol Sci.
- 2015 Nov;58(6):514-517.
- doi: 10.5468/ogs.2015.58.6.514
The cause of recurrent miscarriage (RM) remains unexplained in approximately 30% to 50% cases. The association of inherited thrombotic factors and RM patients has not been documented from the northern... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparative study between light transmission aggregometry and flow cytometric platelet aggregation test for the identification of platelet function defects in patients with bleeding
-
Sharma P, Sachdeva MUS, Kumar N, Bose S, Bose P, Uppal V, Malhotra P, Bansal D, Varma N, Ahluwalia J
- KMID: 2517066
- Blood Res.
- 2021 Jun;56(2):109-118.
- doi: 10.5045/br.2021.2020232
Background Platelet aggregation studies using conventional light transmission aggregometry (LTA) have several disadvantages and require strict pre-analytical measures for reliable results. We aimed to examine the utility of flow cytometric platelet aggregation... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression
-
Srinivasan VK, Naseem S, Varma N, Lad DP, Malhotra P
- KMID: 2507052
- Blood Res.
- 2020 Sep;55(3):131-138.
- doi: 10.5045/br.2020.2020080
Background Chronic lymphocytic leukemia (CLL) is a heterogeneous disease, which is attributed to differences in the genetic characteristics of the leukemic clone. We studied the genomic profile of 52 treatment-naïve CLL... -
- CITED
-
- Close
- SHARE
-
- Close
